Evidence map›Paper›PMID 42481806›Full record

ArticleThe EMBO journal2026

Proteolytic activation of executioner caspase-3 and -7 regulates different physiological processes in mice.

Noëlle Sieg, Johanna Stachelscheid, Besarta Thaqi, Tanja Schwab, Fabian Schorn, Daniela Hahn, Adrian Georg Simon, Yuri Tolkach, Nima Abedpour, Simon E Tröder and 12 more

Abstract read
In one paragraph

Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Noëlle Sieg *University of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Johanna Stachelscheid *University of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.ORCID http://orcid.org/0000-0001-7419-8900
Besarta ThaqiUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Tanja SchwabUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Fabian SchornUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Daniela HahnUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Adrian Georg SimonUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Pathology and Center for Integrated Oncology (CIO) Cologne Bonn, Cologne, Germany.
Yuri TolkachUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Pathology and Center for Integrated Oncology (CIO) Cologne Bonn, Cologne, Germany.
Nima AbedpourUniversity of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, Cologne, Germany.
Simon E TröderUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.ORCID http://orcid.org/0000-0003-1156-2976
Ingo VoigtMax Planck Institute for Biology of Ageing, Cologne, Germany.
Felix GaedkeUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.ORCID http://orcid.org/0000-0002-7744-4940
Katja WiegmannUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Medical Microbiology, Immunology and Hygiene, Cologne, Germany.ORCID http://orcid.org/0009-0002-7658-3604
Susanne BrodesserUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.ORCID http://orcid.org/0000-0001-5631-0663
Astrid SchaussUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.
Branko ZevnikUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany.ORCID http://orcid.org/0000-0001-7845-9522
Martin KrönkeUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Center for Molecular Medicine Cologne (CMMC), Cologne, Germany.
Reinhard BüttnerUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Pathology and Center for Integrated Oncology (CIO) Cologne Bonn, Cologne, Germany.ORCID http://orcid.org/0000-0001-8806-4786
Alexander QuaasUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute of Pathology and Center for Integrated Oncology (CIO) Cologne Bonn, Cologne, Germany.
Michael HallekUniversity of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, Cologne, Germany.
Melanie Fritsch *University of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany.
Hamid Kashkar *University of Cologne, Faculty of Medicine and University Hospital of Cologne, Institute for Molecular Immunology, Cologne, Germany. h.kashkar@uni-koeln.de.ORCID http://orcid.org/0000-0003-2796-1429

Funding

Deutsche Forschungsgemeinschaft (DFG) 269925409Deutsche Forschungsgemeinschaft (DFG) 414786233Deutsche Forschungsgemeinschaft (DFG) 455784452Deutsche Forschungsgemeinschaft (DFG) 501530074Deutsche Forschungsgemeinschaft (DFG) DFG-INST 216793-1 FUGGDeutsche Krebshilfe (German Cancer Aid) 70112113Deutsche Krebshilfe (German Cancer Aid) 70114685Ministerium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (MKW) CANTAR ProjectMinisterium für Kultur und Wissenschaft des Landes Nordrhein-Westfalen (MKW) CCCEUzK | Medizinische Fakultät, Universität zu Köln (Faculty of Medicine, University of Cologne) CCSP Programm
6 · The paper itself

Abstract

Caspase-3 (CASP3) and caspase-7 (CASP7) are the two major executioner caspases that are proteolytically activated by upstream initiator caspases. They possess almost indistinguishable activity, which has led to the overall view that these caspases have functionally redundant roles. Here, we generate knock-in mice expressing cleavage-resistant CASP3(D175A) or CASP7(D198A). Our results show that proteolytic activation of CASP3 and CASP7 is decisive for their activity in vivo and controls redundant processes during embryonic development as combined expression of both CASP3(D175A) and CASP7(D198A) causes embryonic lethality. In adult mice, however, activation of CASP3 and CASP7 controls different processes in different tissues, without the involvement of apoptosis. While CASP7 activation is required for male fertility by controlling spermatogenesis, CASP3 activation appears crucial for lymphoid tissue development by regulating interferon signalling. Our findings shed light on emerging roles of caspases in non-apoptotic processes and provide impetus for reconsidering their involvement in physiological and pathological conditions.

Indexed as

Caspase 3Caspase 7AnimalsApoptosisEmbryonic DevelopmentEnzyme ActivationFemaleGene Knock-In TechniquesMaleMiceProteolysisSpermatogenesisCasp7 protein, mouseCaspase 3Caspase 7

Identifiers

PMID42481806
PMCPMC13534459

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.